Mycophenylate mofetil

DRUG4 trials

Sponsors

Stanford University, Masonic Cancer Center, University of Minnesota, Guy's and St Thomas' NHS Foundation Trust

Conditions

Acute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)AdrenoleukodystrophyBurkitt's LymphomaChronic Lymphocytic LeukemiaChronic Myelogenous LeukemiaDiffuse Large B Cell LymphomaFollicular Lymphoma

Phase 2

Phase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD

CompletedNCT00186628

Stanford UniversityLeukemia, Mast-Cell, Mantle-cell Lymphoma

Start: 2005-06-30End: 2010-12-31Updated: 2017-11-28

HSCT for High Risk Inherited Inborn Errors

CompletedNCT00383448

Masonic Cancer Center, University of MinnesotaAdrenoleukodystrophy, Globoid Cell Leukodystrophy, GM1 Gangliosidosis +6

Start: 2006-09-30End: 2014-09-30Updated: 2019-07-11

Phase 4

RituxiMab INDuction in Renal Transplantation

Guy's and St Thomas' NHS Foundation TrustFunction of Renal Transplant

Start: 2010-11-30End: 2022-10-31Updated: 2020-07-22

Unknown Phase

Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases

RecruitingNCT01962636

Masonic Cancer Center, University of MinnesotaAcute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Burkitt's Lymphoma +15

Start: 2016-12-01End: 2028-02-01Target: 200Updated: 2026-03-12

Related Papers

Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.

2011-05-17200 citations